A Cautious Yes | GenomeWeb

A Cautious Yes

A new survey suggests that many Americans would consider taking part in a clinical trial, but that most of their doctors do not discuss medical research with them, writes Ed Silverman at Pharmalot.

Silverman notes that previously cited reasons for low participation rates in trials include wide access to medication and difficulties in finding participants who are not taking other medications that could influence the trial.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.